RAPT stock forecast
Our latest prediction for Rapt Therapeutics, Inc.'s stock price was made on the Oct. 12, 2020 when the stock price was at 40.23$.
In the short term (2weeks), RAPT's stock price should underperform the market by -2.71%. During that period the price should oscillate between -11.59% and +12.91%.
In the medium term (3months), RAPT's stock price should underperform the market by -6.15%. During that period the price should oscillate between -40.22% and +28.72%.Get email alerts
Create a solid portfolio with RAPT
About Rapt Therapeutics, Inc.
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -1.99$ per share.
The book value per share is 3.00$
Three months stock forecastOct. 12, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|